1. Home
  2. CERS vs OTLY Comparison

CERS vs OTLY Comparison

Compare CERS & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • OTLY
  • Stock Information
  • Founded
  • CERS 1991
  • OTLY 1994
  • Country
  • CERS United States
  • OTLY Sweden
  • Employees
  • CERS N/A
  • OTLY N/A
  • Industry
  • CERS EDP Services
  • OTLY Packaged Foods
  • Sector
  • CERS Technology
  • OTLY Consumer Staples
  • Exchange
  • CERS Nasdaq
  • OTLY Nasdaq
  • Market Cap
  • CERS 347.3M
  • OTLY 395.7M
  • IPO Year
  • CERS 1997
  • OTLY 2021
  • Fundamental
  • Price
  • CERS $1.65
  • OTLY $7.95
  • Analyst Decision
  • CERS Buy
  • OTLY Buy
  • Analyst Count
  • CERS 3
  • OTLY 4
  • Target Price
  • CERS $3.17
  • OTLY $1.20
  • AVG Volume (30 Days)
  • CERS 1.6M
  • OTLY 312.6K
  • Earning Date
  • CERS 02-20-2025
  • OTLY 02-12-2025
  • Dividend Yield
  • CERS N/A
  • OTLY N/A
  • EPS Growth
  • CERS N/A
  • OTLY N/A
  • EPS
  • CERS N/A
  • OTLY N/A
  • Revenue
  • CERS $180,270,000.00
  • OTLY $823,666,000.00
  • Revenue This Year
  • CERS $15.95
  • OTLY $9.21
  • Revenue Next Year
  • CERS $10.50
  • OTLY $7.02
  • P/E Ratio
  • CERS N/A
  • OTLY N/A
  • Revenue Growth
  • CERS 15.29
  • OTLY 5.15
  • 52 Week Low
  • CERS $1.38
  • OTLY $6.00
  • 52 Week High
  • CERS $2.59
  • OTLY $26.80
  • Technical
  • Relative Strength Index (RSI)
  • CERS 41.40
  • OTLY 33.58
  • Support Level
  • CERS $1.64
  • OTLY $6.00
  • Resistance Level
  • CERS $1.96
  • OTLY $10.90
  • Average True Range (ATR)
  • CERS 0.11
  • OTLY 1.40
  • MACD
  • CERS -0.02
  • OTLY -0.28
  • Stochastic Oscillator
  • CERS 3.12
  • OTLY 30.95

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About OTLY Oatly Group AB

Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.

Share on Social Networks: